European Archives - Page 328 of 1472 - European Medical Journal

What HCPs want: Why interactive medical content works

Explore how interactive medical content empowers today’s HCPs to access the information they need in a faster, easier and more engaging way.

New AI-Powered Model Improves Skin Disease Diagnosis

The model integrates four key types of imagery: total-body photographs, standard clinical photos, dermoscopic close-ups, and dermatopathology slides.

Bridging Borders in Women’s Health

This week, the host Saranya Ravindran welcomes Tommaso Falcone, reproductive health pioneer and global healthcare leader. From redefining…

Two Decades On, Atrial Fibrillation Outcomes Show Uneven Progress

Patients with atrial fibrillation now live longer after stroke, heart failure, or myocardial infarction, but bleeding risks remain unchanged.

Does Symptom Provocation Improve Transcranial Magnetic Stimulation?

A large meta-analysis suggests TMS improves clinical outcomes in OCD and nicotine dependence, but the role of symptom provocation needs further study.

New Home-Based Monitoring for Urinary Health Conditions

Discover a study where researchers introduced a conceptual design for a toilet-mounted home device capable of non-invasively measuring urine flow, volume, and frequency.

BMS' Anita Gandhi on a decade of change in hematology

This National Blood Week, the team sit down with Anita Gandhi, BMS, to explore the last decade in hematology and what lies ahead.

A collection of illustrated lab equipment

UK’s 10 Year Health Plan pledges clinical trial overhaul

The UK government has set out a 10 Year Health Plan, promising to transform clinical trials and make the UK a scientific superpower.

Genetic Variants Linked to Early-Onset Lung Cancer in Asian Populations

New research links TP53, BRCA2, and ALKBH2 mutations to early-onset lung cancer in Asian women who have never smoked.

EHA 2025: Circulating Tumour Cells Offer Prognostic Insight in Multiple Myeloma

A large European analysis confirms circulating tumour cells (CTCs) as an independent prognostic biomarker in newly diagnosed multiple myeloma.